We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMS icon
3401
CMS Energy
CMS
$23B
-97
Closed -$6K
CNEY icon
3402
CN Energy Group
CNEY
$4.76M
-29
Closed -$64K
CNP icon
3403
CenterPoint Energy
CNP
$28.9B
-111,001
Closed -$3.1M
CNS icon
3404
Cohen & Steers
CNS
$4.24B
-976
Closed -$91K
CNTB
3405
Connect Biopharma Holdings
CNTB
$131M
-123,109
Closed -$634K
CNXN icon
3406
PC Connection
CNXN
$2.1B
-1,116
Closed -$49K
COF icon
3407
Capital One
COF
$130B
-1,109,779
Closed -$161M
COKE icon
3408
Coca-Cola Consolidated
COKE
$13B
-64,530
Closed -$4M
COLD icon
3409
Americold
COLD
$4.17B
-6,609
Closed -$217K
COOP
3410
DELISTED
Mr. Cooper
COOP
-4,131
Closed -$172K
COR icon
3411
Cencora
COR
$62.2B
-40
Closed -$5K
COTY icon
3412
Coty
COTY
$2.46B
-23,454
Closed -$245K
CPK icon
3413
Chesapeake Utilities
CPK
$3.31B
-198
Closed -$28K
CPIX icon
3414
Cumberland Pharmaceuticals
CPIX
$102M
-79,836
Closed -$373K
CPRX
3415
DELISTED
Catalyst Pharmaceutical
CPRX
-200,308
Closed -$1.36M
CPRI icon
3416
CALL
Capri Holdings
CPRI
$1.88B
-1,800
Closed -$116K
CRAI icon
3417
CRA International
CRAI
$1.16B
-5,496
Closed -$513K
CRCT icon
3418
Cricut
CRCT
$987M
-6,914
Closed -$153K
CRD.A icon
3419
Crawford & Co Class A
CRD.A
$552M
-4,167
Closed -$30K
CRDF icon
3420
Cardiff Oncology
CRDF
$63.4M
-66,876
Closed -$402K
CRH icon
3421
CRH
CRH
$69.1B
-141,797
Closed -$7.49M
CRM icon
3422
CALL
Salesforce
CRM
$149B
-18,900
Closed -$4.8M
CRM icon
3423
PUT
Salesforce
CRM
$149B
-34,200
Closed -$8.69M
CRNX icon
3424
Crinetics Pharmaceuticals
CRNX
$8.87B
-445
Closed -$12K
CRON
3425
Cronos Group
CRON
$1.06B
-339,890
Closed -$1.33M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.